CN102659706A - 一种手性噁唑啉的制备及合成方法 - Google Patents
一种手性噁唑啉的制备及合成方法 Download PDFInfo
- Publication number
- CN102659706A CN102659706A CN2012101166683A CN201210116668A CN102659706A CN 102659706 A CN102659706 A CN 102659706A CN 2012101166683 A CN2012101166683 A CN 2012101166683A CN 201210116668 A CN201210116668 A CN 201210116668A CN 102659706 A CN102659706 A CN 102659706A
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- phenyl
- reaction
- taking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
一种手性噁唑啉的制备,其化学式如下:
Description
一、技术领域
本发明涉及一种新化合物及其制备方法,特别涉及一种手性化合物及其制备方法, 确切地说是一种手性噁唑啉的制备及合成方法。
二、背景技术
手性噁唑啉是重要的医药化工产品及催化剂,近年来,国内外最新报道了种类繁多的双齿,三齿及四齿噁唑啉对氢化反应、Heck 反应、烯丙基烷基化反应、Diels-Alder 反应,二乙基锌对醛的加成反应等具有非常好的催化活性。【1-13】
参考文献:
1. Cozzi, P. G.; Menges, F.; Kaiser, S. Iridium-HetPHOX complexes for the catalytic asymmetric
hydrogenation of olefins and imines, Synlett, 2003, 833-836.
2. Tang, W. J.; Wang, W.M; Zhang, X. M. . Phospholane–Oxazoline Ligands for Ir-Catalyzed
Asymmetric Hydrogenation, Angew . Chem., Int. Ed. Engl. 2003, 42, 943.
3. Hilgraf, R.; Pfaltz, A. Chiral bis(N-tosylamino)phosphine- and TADDOL-phosphite-
oxazolines as ligands in asymmetric catalysis Synlett. 1999, 1814-1816.
4. (a) Powell, M. T.; Hou, D.-R.; Perry, M. C.; Cui, X.; Burgess, K. Chiral Imidazolylidine
Ligands for Asymmetric Hydrogenation of Aryl Alkenes, J. Am.Chem.Soc.2001, 123, 8878-8879.
(b) Perry, M. C.; Cui, X.;Powell, M. T.; Hou, D.-R.; Reibenspies, J. H.; Burgess, K. Optically
Active Iridium Imidazol-2-ylidene-oxazoline Complexes: Preparation and Use in Asymmetric
Hydrogenation of Arylalkenes, J. Am.Chem. Soc. 2003, 125, 113-123.
5. Gilbertson, Scott. R.; Xie, D.J.; Fu, Z. , Proline derived phosphine–oxazoline ligands in the
asymmetric Heck reaction, Tetrahedron Lett. 2001, 42, 365-368.
6. Hashimoto, Y.; Horie, Y.; Hayashi, M.; Saigo, K. An efficient phosphorus-containing
oxazoline ligand derived from cis-2-amino-3,3-dimethyl-1-indanol: application to the
palladium-catalyzed asymmetric Heck reaction Tetrahedron:Asymmetry 2000, 11, 2205-
2210.
7. Tu, T.; Deng, W.-P.; Hou, X.-L.; Dai, L.-X.; Dong, X.-C. The regioselectivity of the
asymmetric intermolecular Heck reaction with planar chiral diphosphine-oxazoline
ferrocenyl ligands Chem.Eur. J. 2003, 9, 3073-3081.
8. Gilbertson, S. R.; Xie, D . Proline-Based P, N Ligands in Palladium-Catalyzed Asymmetric
π-Allyl Addition, Angew. Chem., Int. Ed. Engl. 1999, 38, 2750-2752.
9. Burgess, K.; Porte, A. M. Application of novel phosphine oxazoline ligands in asymmetric
allylations of 4-acyloxy-2-pentene derivatives, Tetrahedron: Asymmetry, 1998, 9, 2465-2469.
10. Bolm, C.; Xiao, L.; Kesselgruber, M. Synthesis of novel chiral phosphinoCyrhetrenyl-
oxazoline ligands and their application in asymmetric catalysis, Org. Biomol. Chem. 2003, 1, 145-152.
11. Watanabe, K.; Hirasawa, T.; Hiroi, K. Lewis acid-catalyzed asymmetric diels-alder reactions
using chiral sulfoxide ligands: Chiral 2-(Arylsulfinylmethyl)-1,3-oxazoline derivatives, Chem. Pharm. Bull. 2002, 50, 372-379.
12. Wipf, P.; Wang, X.D. A new ligand scaffold for catalytic asymmetric alkylzinc additions to
aldehydes , Org. Lett. 2002, 4, 1197-1200.
13. Schinnerl, M.; Seitz, M.; Kaiser, A.; Reiser, O., New applications of bis(oxazoline) ligands in
catalysis: Asymmetric 1,2-and 1,4-addition of ZnR2 to carbonyl compounds, Org. Lett. 2001, 3, 4259-4262.
申请人以7, 7, 8, 8-四氰基奎二甲烷与L-苯甘氨醇在105mol%氯化锌作催化剂下,得到了一种手性化合物 4-[4' (S)-苯基-4,5-二氢化-2-噁唑啉基]-苯乙腈。
一、发明内容
本发明旨在提供手性化合物4-[4' (S)-苯基-4,5-二氢化-2-噁唑啉基]-苯乙腈, 所要解决的技术问题是一步合成得到目标产物。
本发明所称的一种手性化合物是由7, 7, 8, 8-四氰基奎二甲烷与L-苯甘氨醇制备的由以下化学式所示的化合物:
(Ⅰ)
化学名称:4-[4' (S)-苯基-4,5-二氢化-2-噁唑啉基]-苯乙腈,简称化合物(I)。
本合成方法包括合成和分离,所述的合成用105mol% 氯化锌做催化剂,7 ,7, 8, 8-四氰基奎二甲烷4.90mmol,L-苯甘氨醇 90mmol,用50mL氯苯做溶剂,回流反应3天后,柱层析分离,用石油醚/二氯甲烷(3/7)洗脱,将收集的最后组分点自然挥发,得单晶4-[4' (S)-苯基-4,5-二氢化-2-噁唑啉基]-苯乙腈。
合成反应如下:
本合成方法一步得到目标产物,工艺简单,操作方便。该化合物在苯甲醛的腈硅化反应中显示了一定的催化效果,其转化率达48.8%。
其反应机理可推测如下:
7, 7, 8, 8-四氰基奎二甲烷由于在空气及大量路易斯酸催化剂,大大过量的L-苯甘氨醇作用下不稳定,首先经过还原、分解生成了4-氰甲基苯腈,然后与大大过量的L-苯甘氨醇在氯化锌作用下得手性化合物4-[4' (S)-苯基-4,5-二氢化-2-噁唑啉基]-苯乙腈,其反应过程如下:
四、附图说明
图1是4-[4' (S)-苯基-4,5-二氢化-2-噁唑啉基]-苯乙腈的X-衍射分析图。
二、具体实施方式
1. 4-[4' (S)-苯基-4,5-二氢化-2-噁唑啉基]-苯乙腈的制备
在100mL两口瓶中,加入无水ZnCl2 70mg (0.74mmol), 50mL氯苯, 7, 7, 8, 8-四氰基奎二甲烷1.0g (4.90mmol), L-缬氨醇 9.3g, 将混合物在高温下回流72h,停止反应,减压以除去溶剂, ,将剩余物用水溶解,并用CH2Cl2(20mLx3)萃取,有机相用无水硫酸钠干燥,旋转除去溶剂,将粗产品用石油醚/ 二氯甲烷(3:7)柱层析,得无色油状液体, 产率42%; [a]5 D=-18.12o (c = 0.0552, CH2Cl2):1HNMR (500MHz, CDCl3, 27℃), δ (ppm) = 8.07 (d, J=10Hz,1H), 7.26~7.42 (m,7H), 5.37~5.42 (m, 1H), 4.79~4.83 (m, 1H), 4.29 (t, J=Hz, 1H), 3.81(s, 2H); 13CNMR(125MHz, CDCl3, 27℃) 164.1, 142.1, 133.4, 129.3, 128.8, 127.8, 127.6, 126.8, 117.3, 75.0, 70.1, 23.7; IR (KBr):3061, 3030, 2947, 2854, 2249, 1723, 1648, 1614, 1579, 1514, 1494, 1475, 1455, 1416, 1356, 1334, 1318, 1302, 1277, 1252, 1179, 1181, 1113, 1073, 1021, 976, 950, 936, 923, 899, 824, 764, 752, 721, 699, 533, 483; HRMS: m/z (%): C17H14N2O, calcd for C17H14N2O 262.1106; found: 262.1105。
(三)、腈硅化反应应用
2-苯基-2-(三甲硅氧基)乙腈
0.1mmol 化合物I, 苯甲醛0.1mL, TMSCN 0.3 ml (3.3mmol), 2mL二氯甲烷 相继在20~30?C下加入,5天后, 加入水淬灭经柱层后(石油醚/二氯甲烷:5/1),得无色油状液体, 转化率率: 48.8 %;1H NMR (300MHz, CDCl3) 7.56–7.59 (m, 0.9 Hz, 2H), 7.31–7.34 (m, 3H), 5.43 (s, 1H), 0.16 (s, 9H). 13C NMR (75 MHz, CDCl3) 136.1, 128.8(x2), 126.2(x2), 119.1, 63.5, -0.39(x3).
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210116668.3A CN102659706B (zh) | 2012-05-10 | 2012-05-10 | 一种手性噁唑啉的制备及合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210116668.3A CN102659706B (zh) | 2012-05-10 | 2012-05-10 | 一种手性噁唑啉的制备及合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102659706A true CN102659706A (zh) | 2012-09-12 |
CN102659706B CN102659706B (zh) | 2014-10-08 |
Family
ID=46769317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210116668.3A Expired - Fee Related CN102659706B (zh) | 2012-05-10 | 2012-05-10 | 一种手性噁唑啉的制备及合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102659706B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102659707A (zh) * | 2012-04-26 | 2012-09-12 | 罗梅 | 一种手性化合物的制备及用途 |
CN103044346A (zh) * | 2013-01-12 | 2013-04-17 | 罗梅 | 一种手性噁唑啉及其合成方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102225915A (zh) * | 2011-05-16 | 2011-10-26 | 罗梅 | 一种手性噁唑啉及其合成方法 |
CN102229604A (zh) * | 2011-04-22 | 2011-11-02 | 罗梅 | 一种手性噁唑啉的制备及合成方法 |
CN102382138A (zh) * | 2011-07-28 | 2012-03-21 | 罗梅 | 一种手性双膦酰二胺化合物及用途 |
CN102643246A (zh) * | 2012-03-22 | 2012-08-22 | 罗梅 | 一种手性2-羰基噁唑啉的合成方法 |
CN102659633A (zh) * | 2012-04-12 | 2012-09-12 | 罗梅 | 一种手性酰铵盐的合成方法 |
CN102659707A (zh) * | 2012-04-26 | 2012-09-12 | 罗梅 | 一种手性化合物的制备及用途 |
-
2012
- 2012-05-10 CN CN201210116668.3A patent/CN102659706B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102229604A (zh) * | 2011-04-22 | 2011-11-02 | 罗梅 | 一种手性噁唑啉的制备及合成方法 |
CN102225915A (zh) * | 2011-05-16 | 2011-10-26 | 罗梅 | 一种手性噁唑啉及其合成方法 |
CN102382138A (zh) * | 2011-07-28 | 2012-03-21 | 罗梅 | 一种手性双膦酰二胺化合物及用途 |
CN102643246A (zh) * | 2012-03-22 | 2012-08-22 | 罗梅 | 一种手性2-羰基噁唑啉的合成方法 |
CN102659633A (zh) * | 2012-04-12 | 2012-09-12 | 罗梅 | 一种手性酰铵盐的合成方法 |
CN102659707A (zh) * | 2012-04-26 | 2012-09-12 | 罗梅 | 一种手性化合物的制备及用途 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102659707A (zh) * | 2012-04-26 | 2012-09-12 | 罗梅 | 一种手性化合物的制备及用途 |
CN102659707B (zh) * | 2012-04-26 | 2014-10-08 | 罗梅 | 一种手性化合物的制备及用途 |
CN103044346A (zh) * | 2013-01-12 | 2013-04-17 | 罗梅 | 一种手性噁唑啉及其合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102659706B (zh) | 2014-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Tian et al. | Rhodium-catalyzed asymmetric arylation | |
Ferraris et al. | Catalytic, enantioselective alkylation of α-imino esters: The synthesis of nonnatural α-amino acid derivatives | |
Mauleón et al. | Enantioselective synthesis of chiral sulfones by Rh-catalyzed asymmetric addition of boronic acids to α, β-unsaturated 2-pyridyl sulfones | |
Ding et al. | Nickel-Catalyzed Reductive Electrophilic Ring Opening of Cycloketone Oxime Esters with Aroyl Chlorides | |
Wang et al. | NHC ligands tailored for simultaneous regio-and enantiocontrol in nickel-catalyzed reductive couplings | |
Ding et al. | Catalytic asymmetric propargylation | |
Zhang et al. | Copper (I)-catalyzed asymmetric alkylation of unsymmetrical secondary phosphines | |
Ohshima et al. | Platinum-catalyzed direct amination of allylic alcohols under mild conditions: Ligand and microwave effects, Substrate scope, And mechanistic study | |
Xue et al. | A class of benzene backbone-based olefin–sulfoxide ligands for Rh-catalyzed enantioselective addition of arylboronic acids to enones | |
Hu et al. | Rhodium (III) Catalyzed Carboamination of Alkenes Triggered by C–H Activation of N-Phenoxyacetamides under Redox-Neutral Conditions | |
Shintani et al. | Design and synthesis of new chiral phosphorus–olefin bidentate ligands and their use in the rhodium-catalyzed asymmetric addition of organoboroxines to N-sulfonyl imines | |
El-Zaria et al. | m-Carborane-based chiral NBN pincer-metal complexes: synthesis, structure, and application in asymmetric catalysis | |
Hao et al. | A cationic NCN pincer Platinum (II) aquo complex with a bis (imidazolinyl) phenyl ligand: Studies toward its synthesis and asymmetric Friedel–Crafts alkylation of indoles with nitroalkenes | |
Liu et al. | Catalytic highly enantioselective alkylation of aldehydes with deactivated grignard reagents and synthesis of bioactive intermediate secondary arylpropanols | |
Maurer et al. | Development of Catalysts for the Stereoselective Hydrogenation of α, β-Unsaturated Ketones | |
Cao et al. | Pd-catalyzed asymmetric allylic etherizations with oximes by chiral alkene-phosphine ligands | |
Fleury et al. | Cooperative Titanocene and Phosphine Catalysis: Accelerated C–X Activation for the Generation of Reactive Organometallics | |
Khiar et al. | Flexible C 2-symmetric bis-sulfoxides as ligands in enantioselective 1, 4-addition of boronic acids to electron-deficient alkenes | |
Kamikawa et al. | Planar-chiral phosphine-olefin ligands exploiting a (cyclopentadienyl) manganese (I) scaffold to achieve high robustness and high enantioselectivity | |
Zhou et al. | Synthesis of o-Alkenylated 2-Arylbenzoxazoles via Rh-Catalyzed Oxidative Olefination of 2-Arylbenzoxazoles: Scope Investigation, Structural Features, and Mechanism Studies | |
Sasaki et al. | Asymmetric conjugate addition of cis-2-arylethenylboronic acids catalyzed by chiral diene/rhodium complexes: 1, 4-rhodium shift from alkenylrhodium to arylrhodium intermediates | |
Niu et al. | Copper-catalyzed yne-allylic substitutions using stabilized nucleophiles | |
Chouhan et al. | Domino ring-opening/carboxamidation reactions of N-tosyl aziridines and 2-halophenols/pyridinol: efficient synthesis of 1, 4-benzo-and pyrido-oxazepinones | |
Moberg | Molybdenum-catalyzed and tungsten-catalyzed enantioselective allylic substitutions | |
CN105384731B (zh) | 一种手性含胺甲基吡啶噁唑啉的化合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141008 Termination date: 20160510 |
|
CF01 | Termination of patent right due to non-payment of annual fee |